repaglinide has been researched along with Day Blindness in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marshall, V; Shakir, S; Wilton, L | 1 |
1 other study(ies) available for repaglinide and Day Blindness
| Article | Year |
|---|---|
Safety profile of repaglinide as used in general practice in England: results of a prescription-event monitoring study.
Topics: Aged; Carbamates; Cause of Death; Cohort Studies; Diabetes Mellitus, Type 2; Drug Prescriptions; England; Family Practice; Female; Humans; Hypoglycemic Agents; Infant; Middle Aged; Piperidines; Pregnancy; Safety; State Medicine; Survival Analysis; Vision Disorders | 2006 |